Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION ...
{{id}} {{{paragraph}}}
1 HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese HIGHLIGHTS do not include all the INFORMATION needed to use BROMSITE safely and effectively. See full PRESCRIBING INFORMATION for (bromfenac ophthalmic solution) topical ophthalmic administrationInitial US Approval: 1997--------------------------------INDI CATIONS AND USAGE---------------------------------Br omSite is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.
2 5.4 Keratitis and Corneal Reactions Use of topical NSAIDs may result in keratitis. In some susceptible patients, continued use of topical NSAIDs may result in epithelial breakdown, corneal
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}